With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company.

Abbott's inquest into radiopharmaceuticals In 1946, Abbott became the first pharmaceutical company to have a special laboratory for radiopharmaceuticals – a move that led to the creation of the ...

Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of ...

Stocks that can balance both dividends and growth can give investors the best of both worlds. Pharmaceutical company AbbVie ...

Following the robust Q3 performance, Piper Sandler raised ABT’s price target to $133 from $131, keeping an Overweight rating ...

The case for Abbott Laboratories. Abbott Laboratories is one of the world's leading medical device makers. It routinely develops and markets newer products, and its portfolio boas ...

Image source: Getty Images. Abbott Laboratories (NYSE: ABT) makes pharmaceuticals, but the company also has three other winning businesses: medical devices, diagnostics, and nutrition. This ...

Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...

Diversified Product Portfolio: Abbott Laboratories' diverse range of medical devices, diagnostic testing products, ...

“Biosimilars can benefit people in a more sustainable way for healthcare systems,” said Eran Gefen, Head of Global Medical ...

Oppenheimer analyst Suraj Kalia maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...

Abbott India continued to benefit from anti-infectives and medications for gastrointestinal conditions, the company said ...